Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vimex Pharma was a Canadian pharmaceutical company that appears to have operated as a commercial pharma business rather than a clinical-stage biotech developer. Publicly available corporate registry records show the company was incorporated in 1988 and later used the name VIMEX PHARMA INC., with earlier names including Omega International Pharma and Laboratoires Vimex. Limited online evidence suggests it marketed or distributed pharmaceutical products, but detailed information on a proprietary R&D pipeline, therapeutic targets, or clinical-stage programs is not readily available in public sources. The company is no longer active, with corporate records indicating dissolution in November 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vimex Pharma.